Understanding the challenges for formulary decision makers and manufacturers
In the United States outcomes-based contracting (OBC) has long been proposed as a measure to reward innovation, based on actual performance of treatments and interventions in patient populations. However, the perceived and actual challenges in implementation have prevented many innovative contracts from leaving the drafting table.
Recently, the potential use of artificial intelligence (AI) to predict suitable outcomes for patients to mitigate potential challenges has been discussed. ICON is conducting original research with formulary decision makers and with manufacturers, with the following objectives in mind:
The results from this research will be published in a future whitepaper. Reserve your copy today.
Register to reserve your copy of our upcoming whitepaper